Evogene (NYSE: EVGN) reported Q2 EPS of ($0.31), versus ($0.33) reported last year. Revenue for the quarter came in at $3.82 million, versus $5.36 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.